NRX Pharmaceuticals, Inc. (NRXP) Insider Trading

Name: NRX Pharmaceuticals, Inc. (NRXP) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Feb 18, 2026): Joseph Michael Casper (Chief Operating Officer): Grant/Award of 100,000 shares.

Get alerted when insiders trade NRXP

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta